Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 11 de 11
Filter
Add more filters










Publication year range
1.
Prion ; 8(6): 404-10, 2014.
Article in English | MEDLINE | ID: mdl-25495906

ABSTRACT

The tendency of amyloid ß (Aß42) peptide to misfold and aggregate into insoluble amyloid fibrils in Alzheimer's disease (AD) has been well documented. Accumulation of Aß42 fibrils has been correlated with abnormal apoptosis and unscheduled cell division which can also trigger the death of neuronal cells, while oligomers can also exhibit similar activities. While investigations using chemically-synthesized Aß42 peptide have become common practice, there appear to be differences in outcomes from different preparations. In order to resolve this inconsistency, we report 2 separate methods of preparing chemically-synthesized Aß42 and we examined their effects in yeast. Hexafluoroisopropanol pretreatment caused toxicity while, ammonium hydroxide treated Aß42 induced cell proliferation in both C. glabrata and S. cerevisiae. The hexafluoroisopropanol prepared Aß42 had greater tendency to form amyloid on yeast cells as determined by thioflavin T staining followed by flow cytometry and microscopy. Both quiescent and non-quiescent cells were analyzed by these methods of peptide preparation. Non-quiescent cells were susceptible to the toxicity of Aß42 compared with quiescent cells (p < 0.005). These data explain the discrepancy in the previous publications about the effects of chemically-synthesized Aß42 on yeast cells. The effect of Aß42 on yeast cells was independent of the size of the peptide aggregates. However, the Aß42 pretreatment determined whether the molecular conformation of peptide resulted in proliferation or toxicity in yeast based assays.


Subject(s)
Amyloid beta-Peptides/chemistry , Candida glabrata/cytology , Peptide Fragments/chemistry , Saccharomyces cerevisiae/cytology , Alzheimer Disease/metabolism , Apoptosis , Benzothiazoles , Flow Cytometry , Microscopy, Confocal , Microscopy, Electron, Transmission , Neurons/metabolism , Peptides/chemistry , Propanols/chemistry , Protein Binding , Protein Conformation , Thiazoles/chemistry
2.
Biochem Biophys Res Commun ; 453(3): 449-54, 2014 Oct 24.
Article in English | MEDLINE | ID: mdl-25281534

ABSTRACT

Self association of the amyloid-ß (Aß42) peptide into oligomers, high molecular weight forms, fibrils and ultimately neuritic plaques, has been correlated with progressive cognitive decline in Alzheimer's disease. Thus, insights into the drivers of the aggregation pathway have the capacity to significantly contribute to our understanding of disease mechanism. Functional assays and a three-dimensional crystal structure of the P3 amyloidogenic region 18-41 of Aß were used to identify residues important in self-association and to design novel non-aggregating variants of the peptide. Biophysical studies (gel filtration, SDS-PAGE, dynamic light scattering, thioflavin T assay, and electron microscopy) demonstrate that in contrast to wild type Aß these targeted mutations lose the ability to self-associate. Loss of aggregation also correlates with reduced neuronal toxicity. Our results highlight residues and regions of the Aß peptide important for future targeting agents aimed at the amelioration of Alzheimer's disease.


Subject(s)
Amyloid beta-Peptides/metabolism , Peptides/metabolism , Amyloid beta-Peptides/chemistry , Amyloid beta-Peptides/genetics , Animals , Benzothiazoles , Microscopy, Electron, Scanning , Mutation , PC12 Cells , Peptides/chemistry , Rats , Thiazoles/metabolism
4.
Proteins ; 81(10): 1748-58, 2013 Oct.
Article in English | MEDLINE | ID: mdl-23609990

ABSTRACT

Alzheimer's disease is the most common form of dementia in humans and is related to the accumulation of the amyloid-ß (Aß) peptide and its interaction with metals (Cu, Fe, and Zn) in the brain. Crystallographic structural information about Aß peptide deposits and the details of the metal-binding site is limited owing to the heterogeneous nature of aggregation states formed by the peptide. Here, we present a crystal structure of Aß residues 1-16 fused to the N-terminus of the Escherichia coli immunity protein Im7, and stabilized with the fragment antigen binding fragment of the anti-Aß N-terminal antibody WO2. The structure demonstrates that Aß residues 10-16, which are not in complex with the antibody, adopt a mixture of local polyproline II-helix and turn type conformations, enhancing cooperativity between the two adjacent histidine residues His13 and His14. Furthermore, this relatively rigid region of Aß (residues, 10-16) appear as an almost independent unit available for trapping metal ions and provides a rationale for the His13-metal-His14 coordination in the Aß1-16 fragment implicated in Aß metal binding. This novel structure, therefore, has the potential to provide a foundation for investigating the effect of metal ion binding to Aß and illustrates a potential target for the development of future Alzheimer's disease therapeutics aimed at stabilizing the N-terminal monomer structure, in particular residues His13 and His14, and preventing Aß metal-binding-induced neurotoxicity.


Subject(s)
Amyloid beta-Peptides/chemistry , Recombinant Fusion Proteins/chemistry , Amino Acid Sequence , Amyloid beta-Peptides/genetics , Amyloid beta-Peptides/metabolism , Antibodies, Monoclonal/chemistry , Antibodies, Monoclonal/genetics , Antibodies, Monoclonal/metabolism , Escherichia coli , Humans , Immunoglobulin Fab Fragments/chemistry , Immunoglobulin Fab Fragments/genetics , Immunoglobulin Fab Fragments/metabolism , Models, Molecular , Molecular Sequence Data , Recombinant Fusion Proteins/genetics , Recombinant Fusion Proteins/metabolism
5.
J Alzheimers Dis ; 32(4): 949-67, 2012.
Article in English | MEDLINE | ID: mdl-22903131

ABSTRACT

Latrepirdine (Dimebon), an anti-histamine, has shown some benefits in trials of neurodegenerative diseases characterized by accumulation of aggregated or misfolded protein such as Alzheimer's disease (AD) and has been shown to promote the removal of α-synuclein protein aggregates in vivo. An important pathway for removal of aggregated or misfolded proteins is the autophagy-lysosomal pathway, which has been implicated in AD pathogenesis, and enhancing this pathway has been shown to have therapeutic potential in AD and other proteinopathies. Here we use a yeast model, Saccharomyces cerevisiae, to investigate whether latrepirdine can enhance autophagy and reduce levels of amyloid-ß (Aß)42 aggregates. Latrepirdine was shown to upregulate yeast vacuolar (lysosomal) activity and promote transport of the autophagic marker (Atg8) to the vacuole. Using an in vitro green fluorescent protein (GFP) tagged Aß yeast expression system, we investigated whether latrepirdine-enhanced autophagy was associated with a reduction in levels of intracellular GFP-Aß42. GFP-Aß42 was localized into punctate patterns compared to the diffuse cytosolic pattern of GFP and the GFP-Aß42 (19:34), which does not aggregate. In the autophagy deficient mutant (Atg8Δ), GFP-Aß42 showed a more diffuse cytosolic localization, reflecting the inability of this mutant to sequester GFP-Aß42. Similar to rapamycin, we observed that latrepirdine significantly reduced GFP-Aß42 in wild-type compared to the Atg8Δ mutant. Further, latrepirdine treatment attenuated Aß42-induced toxicity in wild-type cells but not in the Atg8Δ mutant. Together, our findings provide evidence for a novel mechanism of action for latrepirdine in inducing autophagy and reducing intracellular levels of GFP-Aß42.


Subject(s)
Amyloid beta-Peptides/antagonists & inhibitors , Autophagy/physiology , Green Fluorescent Proteins/metabolism , Indoles/pharmacology , Intracellular Fluid/metabolism , Peptide Fragments/antagonists & inhibitors , Saccharomyces cerevisiae/metabolism , Amyloid beta-Peptides/metabolism , Autophagy/drug effects , Down-Regulation/drug effects , Green Fluorescent Proteins/antagonists & inhibitors , Humans , Intracellular Fluid/drug effects , Peptide Fragments/metabolism , Saccharomyces cerevisiae/cytology , Saccharomyces cerevisiae/drug effects , Up-Regulation/drug effects
6.
Biotechnol Bioeng ; 109(6): 1461-70, 2012 Jun.
Article in English | MEDLINE | ID: mdl-22170409

ABSTRACT

Sortase-mediated protein ligation is a biological covalent conjugation system developed from the enzymatic cell wall display mechanism found in Staphylococcus aureus. This three-component system requires: (i) purified Sortase A (SrtA) enzyme; (ii) a substrate containing the LPXTG peptide recognition sequence; and (iii) an oligo-glycine acceptor molecule. We describe cloning of the single-chain antibody sc528, which binds to the extracellular domain of the epidermal growth factor receptor (EGFR), from the parental monoclonal antibody and incorporation of a LPETGG tag sequence. Utilizing recombinant SrtA, we demonstrate successful incorporation of biotin from GGG-biotin onto sc528. EGFR is an important cancer target and is over-expressed in human tumor tissues and cancer lines, such as the A431 epithelial carcinoma cells. SrtA-biotinylated sc528 specifically bound EGFR expressed on A431 cells, but not negative control lines. Similarly, when sc528 was labeled with fluorescein we observed antigen-specific labeling. The ability to introduce functionality into recombinant antibodies in a controlled, site-specific manner has applications in experimental, diagnostic, and potentially clinical settings. For example, we demonstrate addition of all three reaction components in situ within a biosensor flow cell, resulting in oriented covalent capture and presentation of sc528, and determination of precise affinities for the antibody-receptor interaction.


Subject(s)
Aminoacyltransferases/metabolism , Bacterial Proteins/metabolism , Cysteine Endopeptidases/metabolism , ErbB Receptors/antagonists & inhibitors , Single-Chain Antibodies/metabolism , Staining and Labeling/methods , Aminoacyltransferases/genetics , Antibodies, Blocking/genetics , Antibodies, Blocking/immunology , Antibodies, Blocking/metabolism , Bacterial Proteins/genetics , Biotin/metabolism , Cell Line, Tumor , Cysteine Endopeptidases/genetics , ErbB Receptors/immunology , Humans , Recombinant Fusion Proteins/genetics , Recombinant Fusion Proteins/metabolism , Single-Chain Antibodies/genetics , Single-Chain Antibodies/immunology
7.
Biochem Biophys Res Commun ; 409(3): 477-82, 2011 Jun 10.
Article in English | MEDLINE | ID: mdl-21600886

ABSTRACT

This study has found that the Maltose binding protein Aß42 fusion protein (MBP-Aß42) forms soluble oligomers while the shorter MBP-Aß16 fusion and control MBP did not. MBP-Aß42, but neither MBP-Aß16 nor control MBP, was toxic in a dose-dependent manner in both yeast and primary cortical neuronal cells. This study demonstrates the potential utility of MBP-Aß42 as a reagent for drug screening assays in yeast and neuronal cell cultures and as a candidate for further Aß42 characterization.


Subject(s)
Amyloid beta-Peptides/chemistry , Amyloid beta-Peptides/toxicity , Neurons/drug effects , Peptide Fragments/chemistry , Peptide Fragments/toxicity , Recombinant Fusion Proteins/chemistry , Recombinant Fusion Proteins/toxicity , Amyloid beta-Peptides/genetics , Animals , Apoptosis , Cerebral Cortex/cytology , Maltose-Binding Proteins/chemistry , Maltose-Binding Proteins/genetics , Maltose-Binding Proteins/toxicity , Mice , Peptide Fragments/genetics , Protein Multimerization , Recombinant Fusion Proteins/genetics , Saccharomyces cerevisiae/drug effects , Solubility
8.
Bioorg Med Chem Lett ; 19(4): 1071-4, 2009 Feb 15.
Article in English | MEDLINE | ID: mdl-19171483

ABSTRACT

Inhibitors of phenylethanolamine N-methyltransferase [PNMT, the enzyme that catalyzes the final step in the biosynthesis of epinephrine (Epi)] may be of use in determining the role of Epi in the central nervous system. Here we describe the synthesis and characterization of 7-SCN tetrahydroisoquinoline as an affinity label for human PNMT.


Subject(s)
Phenylethanolamine N-Methyltransferase/metabolism , Tetrahydroisoquinolines/chemical synthesis , Tetrahydroisoquinolines/pharmacology , Animals , Epinephrine/metabolism , Epinephrine/physiology , Humans , Phenylethanolamine N-Methyltransferase/antagonists & inhibitors , Rats , Tetrahydroisoquinolines/chemistry , Time Factors
9.
J Med Chem ; 47(1): 37-44, 2004 Jan 01.
Article in English | MEDLINE | ID: mdl-14695818

ABSTRACT

The crystal structures of human phenylethanolamine N-methyltransferase in complex with S-adenosyl-l-homocysteine (7, AdoHcy) and either 7-iodo-1,2,3,4-tetrahydroisoquinoline (2) or 8,9-dichloro-2,3,4,5-tetrahydro-1H-2-benzazepine (3, LY134046) were determined and compared with the structure of the enzyme complex with 7 and 7-aminosulfonyl-1,2,3,4-tetrahydroisoquinoline (1, SK&F 29661). The enzyme is able to accommodate a variety of chemically disparate functional groups on the aromatic ring of the inhibitors through adaptation of the binding pocket for this substituent and by subtle adjustments of the orientation of the inhibitors within the relatively planar binding site. In addition, the interactions formed by the amine nitrogen of all three inhibitors reinforce the hypothesis that this functional group mimics the beta-hydroxyl of norepinephrine rather than the amine. These studies provide further clues for the development of improved inhibitors for use as pharmacological probes.


Subject(s)
Epinephrine/biosynthesis , Phenylethanolamine N-Methyltransferase/antagonists & inhibitors , Benzazepines/chemistry , Binding Sites , Crystallography, X-Ray , Humans , Isoquinolines/chemistry , Models, Molecular , Phenylethanolamine N-Methyltransferase/chemistry , Phenylethanolamine N-Methyltransferase/metabolism , Protein Binding , Quinolines/chemistry , S-Adenosylhomocysteine/chemistry , Substrate Specificity
10.
Protein Sci ; 12(4): 734-47, 2003 Apr.
Article in English | MEDLINE | ID: mdl-12649432

ABSTRACT

Single-chain variable fragments (scFvs) of anti-Lewis(y) hu3S193 humanized antibody were constructed by joining the V(H) and V(L) domains with either +2 residues, +1 residue, or by directly linking the domains. In addition two constructs were synthesized in which one or two C-terminal residues of the V(H) domain were removed (-1 residue, -2 residue) and then joined directly to the V(L) domain. An scFv construct in the reverse orientation with the V(L) joined directly to the V(H) domain was also synthesized. Upon transformation into Escherichia coli all scFv constructs expressed active protein. Binding activity, multimeric status, and multivalent properties were assessed by flow cytometry, size exclusion chromatography, and biosensor analysis. The results for hu3S193 scFvs are consistent with the paradigm that scFvs with a linker of +3 residues or more associate to form a non-covalent dimer, and those with a shorter linker or directly linked associate predominantly to form a non-covalent trimer and tetramer that are in equilibrium. While the association of V domains to form either a dimer or trimer/tetramer is governed by the length of the linker, the stability of the trimer/tetramer in the equilibrium mixture is dependent on the affinity of the interaction of the individual V domains to associate to form the larger Fv module.


Subject(s)
Immunoglobulin Fragments/immunology , Lewis Blood Group Antigens/immunology , Chromatography, Gel , Electrophoresis, Polyacrylamide Gel , Flow Cytometry , Fluorescence , Humans , Immunoglobulin Fragments/genetics
11.
Acta Crystallogr D Biol Crystallogr ; 58(Pt 2): 314-5, 2002 Feb.
Article in English | MEDLINE | ID: mdl-11807261

ABSTRACT

Phenylethanolamine N-methyltransferase, PNMT, utilizes the methylating cofactor S-adenosyl-L-methionine to catalyse the synthesis of adrenaline. Human PNMT has been crystallized in complex with an inhibitor and the cofactor product S-adenosyl-L-homocysteine using the hanging-drop technique with PEG 6000 and lithium chloride as precipitant. A critical requirement for crystallization was a high enzyme concentration (>90 mg ml(-1)) and cryocrystallography was used for high-quality data measurement. Diffraction data measured from a cryocooled crystal extend to a resolution of 2.3 A. Cryocooled crystals belong to space group P4(3)2(1)2 and have unit-cell parameters a = b = 94.3, c = 187.7 A.


Subject(s)
Phenylethanolamine N-Methyltransferase/chemistry , Crystallization , Crystallography, X-Ray , Epinephrine/metabolism , Humans , Lithium Chloride/chemistry , Phenylethanolamine N-Methyltransferase/metabolism , Polyethylene Glycols/chemistry , Protein Conformation , S-Adenosylhomocysteine/chemistry , S-Adenosylhomocysteine/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...